mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.2 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |